Human Microbiome Market to Grow at a CAGR of 21.8% to reach US$ 1,197.08 Million from 2017 to 2025

Human Microbiome Market Forecast to 2025 - COVID-19 Impact and Global Analysis by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Geography

Publication Month: Aug 2020 | Report Code: TIPBT00002233 | No. of Pages: 183 | Category: Biotechnology | Status: Published
Covid

The human microbiome market was valued at US$ 257.30 million in 2017 and is projected to reach US$ 1,197.08 million in 2025. it is expected to grow at a CAGR of 21.8% from 2018 to 2025.

The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut, the human microbiome consists of the genes these cells harbor. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body

The scope of the human microbiome market includes product, application, disease, and region. The market for human microbiome is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the N human microbiome market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.

Lucrative Regions for Human Microbiome Market

Lucrative Regions for Human Microbiome Market

Get more information on this report :



Market Insights

Increasing Incidences of lifestyle Diseases

Over the past few decades, human microbiome is related to lifestyle diseases like cancer, diabetes, obesity, depression and many others. Changes in lifestyles and societal norms influence the microbiome at each stage of life. Altering the human microbiome can help in eliminating such lifestyle diseases. As per World health organization in 2016, 13% of the world population (adults) were obese. According to the “The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation” published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity. Therefore, fecal/gut microbiome transplantation (GMT), which involves the transfer of feces from a healthy donor to the patient, is a potential treatment for obesity.

Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. According to the International Diabetes Federation (IDF), in 2017, number of people with diabetes in North America was approximately 46 million which is expected to grow at 62 million in 2045. The increase in the disease prevalence is around 35% during the forecast period. The microbiome of patients with diabetes is characterized by reduced levels of Firmicutes, Clostridia, butyrate-producing bacteria and an increased ratio of Bacteroidetes: Firmicutes. Thus, by altering the microbiome by prebiotics, probiotics, fecal transplantation diabetes can be prevented as well as treated.     

Human Microbiome Product -Based Insights                  

Based on product, the human microbiome market is segmented food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, probiotics accounted for the largest share of the market. The growth of the market is attributed to increasing health concerns, growing awareness regarding the relation of nutrition, diet, and health, and increasing probiotics market penetration in dairy and other food and beverages industry is expected to favor the overall demand.

Global Human Microbiome Market, by Product – 2017 & 2025

Global Human Microbiome Market, by Product – 2017 & 2025

Get more information on this report :


 

Type - Application

Based on the application the market is segment into diagnostics and therapeutics. In 2017, therapeutics segment held the largest share and expected to grow at highest CAGR of 22.2% in the market during the forecast period

Disease -Based Insights

Based on the disease the market is segment into diabetes, cancer, autoimmune disorders, obesity, mental disorders and other diseases. In 2017, obesity accounted for the largest share of the market. However, diabetes segment is growing at highest CAGR of 22.8% in the market during the forecast period

Product launches and expansion strategies are commonly adopted by companies to expand their footprint and product portfolio worldwide as well as to meet the growing demand.

The market players operating in the human microbiome market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

Global Human Microbiome Market – By Product
  • Probiotics
  • Foods
  • Prebiotics
  • Medical Foods
  • Diagnostic Device
  • Drugs
  • Supplements
Global Human Microbiome Market – By Disease
  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Mental Disorders
  • Others
Global Human Microbiome Market – By Application
  • Therapeutics
  • Diagnostics
Global Human Microbiome Market – By Geography
  • North America
      • U.S.
      • Canada
      • Mexico
  • Europe
      • U.K.
      • Germany
      • France
  • Asia Pacific (APAC)
      • Japan
      • China
      • India
  • Middle East & Africa (MEA)
      • South Africa
      • UAE
      • Saudi Arabia
  • South & Central America (SCAM)
      • Brazil

Company Profiles

  • Enterome
  • REBIOTIX INC
  • YAKULT HONSHA CO., LTD
  • OSEL INC
  • VEDANTA BIOSCIENCES, INC
  • SYNTHETIC BIOLOGICS, INC
  • DUPONT
  • BIOMX
  • MaaT Pharma
  • Eligo Bioscience
  • Merck & Co., Inc
  • AOBiome LLC
  • Kaleido
  • Seres Therapeutics

1.             INTRODUCTION

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

2.             Global Human microbiome Market –  Key takeaways

3.             Global Human microbiome market –  market landscape

3.1       overview

3.2       market segmentation

3.2.1        Global Human Microbiome Market – By Product

3.2.2        Global Human Microbiome Market – By Disease

3.2.3        Global Human Microbiome Market – By Application

3.2.4        Global Human Microbiome Market – By Geography

3.3       PEST Analysis

3.3.1        North America – PEST Analysis

3.3.2        Europe– PEST Analysis

3.3.3        Asia Pacific– PEST Analysis

3.3.4        Middle East And Africa– PEST Analysis

3.3.5        South and Central America – PEST Analysis

4.             Global HUMAN MICROBIOME market – Key Market Dynamics

4.1       Key Market Drivers

4.1.1        Increasing Incidence of Lifestyle Diseases

4.1.2        Increasing Focus On Human Microbiome Therapies

4.1.3        Growing Technological Advancements in Metagenomics and Next-generation Sequencing

4.2       Key Market Restraints

4.2.1        Strict Government Guidelines

4.2.2        Lack of Knowledge and Detailed Examination

4.3       Key Market Opportunities

4.3.1        New Drug Requirements for Faecal Microbiota

4.3.2        Emerging Nations

4.4       future Trends

4.4.1        The Human Microbiome - A New Frontier in Drug Discovery

4.5       Impact analysis

5.             Human microbiome market – Global Analysis

5.1       global Human microbiome market Revenue Forecasts and Analysis

5.2       global Human microbiome market, By Geography - Forecasts and Analysis

5.3       Market positioning

5.4       PERFORMANCE OF KEY PLAYERS

5.4.1        Enterome

5.4.2        Yakult Honsha Co., Ltd.

5.5       expert opinions

6.             Global Human microbiome market Analysis –  By Product

6.1       Overview

6.2       GLOBAL Human microbiome MARKET, BY product, 2017 & 2025 (%)

6.3       FOODS Market

6.3.1        Overview

6.3.2        Global Foods Market Revenue and Forecasts to 2025 (US$ Mn)

6.4       Medical food Market

6.4.1        Overview

6.4.2        Global Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)

6.5       probiotics Market

6.5.1        Overview

6.5.2        Global Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.6       prebiotics Market

6.6.1        Overview

6.6.2        Global Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.7       drugs Market

6.7.1        Overview

6.7.2        Global Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

6.8       DIAGNOSTIC DEVICES Market

6.8.1        Overview

6.8.2        Global Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)

6.9       SUPPLEMENTS Market

6.9.1        Overview

6.9.2        Global Supplements Market Revenue and Forecasts to 2025 (US$ Mn)

7.             Global human microbiome market Analysis –  By disease

7.1       Overview

7.2       GLOBAL Human microbiome MARKET, BY disease, 2017 & 2025 (%)

7.3       diabetes Market

7.3.1        Overview

7.3.2        Global Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)

7.4       CANCER Market

7.4.1        Overview

7.4.2        Global Cancer Market Revenue and Forecasts to 2025 (US$ Mn)

7.5       AUTOIMMUNE DISORDERS Market

7.5.1        Overview

7.5.2        Global Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.6       OBESITY Market

7.6.1        Overview

7.6.2        Global Obesity Market Revenue and Forecasts to 2025 (US$ Mn)

7.7       MENTAL DISORDERS Market

7.7.1        Overview

7.7.2        Global Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.8       Others Market

7.8.1        Overview

7.8.2        Global Others Market Revenue and Forecasts to 2025 (US$ Mn)

8.             Global human microbiome market Analysis –  By application

8.1       Overview

8.2       GLOBAL Human microbiome MARKET, BY application, 2017 & 2025 (%)

8.3       Diagnostics Market

8.3.1        Overview

8.3.2        Global Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)

8.4       therapeutics Market

8.4.1        Overview

8.4.2        Global Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

9.             North America human microbiome market Revenue and Forecasts to 2025

9.1       Overview

9.2       North America human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

9.3       North America Human microbiome market Revenue And Forecasts to 2025, By Product  (US$ Mn)

9.4       North America Human microbiome market Revenue And Forecasts to 2025, By disease  (US$ Mn)

9.5       North America Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.6       North America Human microbiome market Revenue And Forecasts to 2025, By Country (%)

9.7       US Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

9.7.1        US Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.7.2        US Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.7.3        US Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.7.4        US Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.8       Canada Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

9.8.1        Canada Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.8.2        Canada Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.8.3        Canada Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.8.4        Canada Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.9       Mexico Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

9.9.1        Mexico Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.9.2        Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.9.3        Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.9.4        Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

10.          Europe Human microbiome market Revenue and Forecasts to 2025

10.1    Overview

10.2    Europe Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

10.3    Europe Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

10.4    Europe Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

10.5    Europe Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)

10.6    Europe Human microbiome market Revenue And Forecasts to 2025, By Country (%)

10.7    UK Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

10.7.1     UK Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

10.7.2     UK Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

10.7.3     UK Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

10.7.4     UK Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

10.8    Germany Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

10.8.1     Germany Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

10.8.2     Germany Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

10.8.3     Germany Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

10.8.4     Germany Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

10.9    France Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

10.9.1     France Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

10.9.2     France Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

10.9.3     France Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

10.9.4     France Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

11.          Asia Pacific Human microbiome Market Revenue and Forecasts to 2025

11.1    Overview

11.2    asia pacific Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

11.3    Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

11.4    Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

11.5    Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Application  (US$ Mn)

11.6    Asia Pacific Genomics Market Revenue And Forecasts to 2025, By Country (%)

11.7    China Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

11.7.1     China Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

11.7.2     China Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

11.7.3     China Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

11.7.4     China Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

11.8    Japan Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

11.8.1     Japan Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

11.8.2     Japan Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

11.8.3     Japan Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

11.8.4     Japan Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

11.9    India Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

11.9.1     India Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

11.9.2     India Human microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

11.9.3     India Human microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

11.9.4     India Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

12.          Middle East and Africa Human microbiome Market Revenue and Forecasts to 2025

12.1    Overview

12.2    Middle East and Africa Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

12.3    Middle East and Africa Human microbiome market Revenue And Forecasts to 2025,  By Product (US$ Mn)

12.4    Middle East and Africa Human microbiome market Revenue And Forecasts to 2025,  By Disease (US$ Mn)

12.5    Middle East and Africa Human microbiome market Revenue And Forecasts to 2025,  By Application (US$ Mn)

12.6    Middle East and Africa and Africa Human microbiome Market Revenue And Forecasts to 2025, By Country (US$ Mn)

12.7    UAE Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

12.7.1     UAE Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

12.7.2     UAE Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

12.7.3     UAE Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

12.7.4     UAE Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

12.8    Saudi Arabia Epigentics Market Revenue and Forecasts to 2025 (US$ Mn)

12.8.1     Saudi Arabia Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

12.8.2     Saudi Arabia Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

12.8.3     Saudi Arabia Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

12.8.4     Saudi Arabia Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

12.9    South Africa Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

12.9.1     South Africa Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

12.9.2     South Africa Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

12.9.3     South Africa Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

12.9.4     South Africa Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

13.          South and Central America epigentics Market Revenue and Forecasts to 2025

13.1    Overview

13.2    South and Central America Human microbiome Market Revenue and Forecasts to 2025  (US$ Mn)

13.3    South and Central America Human microbiome market Revenue And Forecasts to 2025,  By Product (US$ Mn)

13.4    South and Central America Human microbiome market Revenue And Forecasts to 2025,  By Disease (US$ Mn)

13.5    South and Central America Human microbiome market Revenue And Forecasts to 2025,  By Application (US$ Mn)

13.6    South and Central America Human microbiome Market Revenue And Forecasts to 2025,  By Country (%)

13.7    Brazil Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

13.7.1     Brazil Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

13.7.2     Brazil Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

13.7.3     Brazil Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

13.7.4     Brazil Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

14.          Impact Of COVID-19 Pandemic On Global Human Microbiome Market

14.1    North America: Impact Assessment of COVID-19 Pandemic

14.2    Europe: Impact Assessment of COVID-19 Pandemic

14.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

14.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

15.          Human Microbiome Market –Industry Landscape

15.1    Overview

15.2    Growth Strategies in the Human Microbiome Market, 2015-2020

15.3    Organic Growth Strategies

15.3.1     Overview

15.3.2     Product Launch & Approvals

15.3.3     Expansion

15.3.4     Patent and license

15.4    Inorganic Growth Strategies

15.4.1     Overview

15.4.2     Acquisitions

15.4.3     Partnerships, Collaborations & Agreements

15.4.4     Joint Ventures

16.          Human microbiome Market–Key company profiles

16.1    ENTEROME

16.1.1     Key Facts

16.1.2     Business Description

16.1.3     Financial Overview

16.1.4     Product Portfolio

16.1.5     SWOT Analysis

16.1.6     Key Developments

16.2    Rebiotix Inc.

16.2.1     Key Facts

16.2.2     Business Description

16.2.3     Financial Overview

16.2.4     Product Portfolio

16.2.5     SWOT Analysis

16.2.6     Key Developments

16.3    Yakult Honsha Co., Ltd.

16.3.1     Key Facts

16.3.2     Business Description

16.3.3     Financial Overview

16.3.4     Product Portfolio

16.3.5     SWOT Analysis

16.3.6     Key Developments

16.4    Osel Inc.

16.4.1     Key Facts

16.4.2     Business Description

16.4.3     Financial Overview

16.4.4     Product Portfolio

16.4.5     Swot Analysis

16.4.6     Key Developments

16.5    Vedanta Biosciences, Inc.

16.5.1     Key Facts

16.5.2     Business Description

16.5.3     Financial Information

16.5.4     Product Portfolio

16.5.5     SWOT Analysis

16.5.6     Key Developments

16.6    Synthetic Biologics, Inc.

16.6.1     Key Facts

16.6.2     Business Description

16.6.3     Financial Information

16.6.4     Product Portfolio

16.6.5     SWOT Analysis

16.6.6     Key Developments

16.7    DuPont

16.7.1     Key Facts

16.7.2     Business Description

16.7.3     Financial Overview

16.7.4     Product Portfolio

16.7.5     SWOT Analysis

16.7.6     Key Developments

16.8    BiomX

16.8.1     Key Facts

16.8.2     Business Description

16.8.3     Financial Information

16.8.4     Product Portfolio

16.8.5     SWOT Analysis

16.8.6     Key Developments

16.9    MaaT Pharma

16.9.1     Key Facts

16.9.2     Business Description

16.9.3     Products and Services

16.9.4     Financial Overview

16.9.5     SWOT Analysis

16.9.6     Key Developments

16.10 ELIGO BIOSCIENCE

16.10.1   Key Facts

16.10.2   Business Description

16.10.3   Products and Services

16.10.4   Financial Overview

16.10.5   SWOT Analysis

16.10.6   Key Developments

16.11 AOBiome

16.11.1   Key Facts

16.11.2   Business Description

16.11.3   Products and Services

16.11.4   Financial Overview

16.11.5   SWOT Analysis

16.11.6   Key Developments

16.12 Kaleido Biosciences, Inc.

16.12.1   Key Facts

16.12.2   Business Description

16.12.3   Products and Services

16.12.4   Financial Overview

16.12.5   SWOT Analysis

16.12.6   Key Developments

16.13 Seres Therapeutics

16.13.1   Key Facts

16.13.2   Business Description

16.13.3   Products and Services

16.13.4   Financial Overview

16.13.5   SWOT Analysis

16.13.6   Key Developments

16.14 Merck & Co., Inc.

16.14.1   Key Facts

16.14.2   Business Description

16.14.3   Products and Services

16.14.4   Financial Overview

16.14.5   SWOT Analysis

16.14.6   Key Developments

17.          Appendix

17.1    About The Insight Partners

17.2    Glossary of Terms

17.3    Methodology

17.3.1     Coverage

17.3.2     Secondary Research

17.3.3     Primary Research

LIST OF TABLES

TABLE 1.           North America Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)

TABLE 2.           North AmericaHuman microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 3.           North America Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 4.           US Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 5.           US Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 6.           US Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 7.           Canada Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 8.           Canada Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 9.           Canada Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 10.        Mexico Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 11.        Mexico Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 12.        Mexico Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 13.        Europe Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)

TABLE 14.        Europe Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 15.        Europe Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 16.        UK Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 17.        UK Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 18.        UK Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 19.        Germany Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 20.        Germany Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 21.        Germany Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 22.        France Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 23.        France Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 24.        France Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 25.        Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)

TABLE 26.        Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 27.        Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 28.        China Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 29.        China Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 30.        China Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 31.        Japan Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 32.        Japan Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)

TABLE 33.        Japan Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 34.        India Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 35.        India Human microbiome market Revenue And Forecasts to 2025, By Disease (US$ Mn)

TABLE 36.        India Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 37.        Middle East and Africa Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)

TABLE 38.        Middle East and Africa Human microbiome market Revenue And Forecasts to 2025, By Disease  (US$ Mn)

TABLE 39.        Middle East and Africa Human microbiome market Revenue And Forecasts to 2025,  By application (US$ Mn)

TABLE 40.        Middle East and Africa human microbiome Market Revenue And Forecasts to 2025, By Country (US$ Mn)

TABLE 41.        UAE Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 42.        UAE Human microbiome market Revenue And Forecasts to 2025, By Disease (US$ Mn)

TABLE 43.        UAE Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 44.        Saudi Arabia Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 45.        Saudi Arabia Human microbiome market Revenue And Forecasts to 2025, By Disease (US$ Mn)

TABLE 46.        Saudi Arabia Human microbiome market Revenue And Forecasts to 2025, By application  (US$ Mn)

TABLE 47.        South Africa Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 48.        South Africa Human microbiome market Revenue And Forecasts to 2025, By Disease (US$ Mn)

TABLE 49.        South Africa Human microbiome market Revenue And Forecasts to 2025, By application  (US$ Mn)

TABLE 50.        South and Central America Human microbiome market Revenue And Forecasts to 2025,  By product (US$ Mn)

TABLE 51.        South and Central America Human microbiome market Revenue And Forecasts to 2025,  By Disease (US$ Mn)

TABLE 52.        South and Central America Human microbiome market Revenue And Forecasts to 2025,  By application (US$ Mn)

TABLE 53.        Brazil Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)

TABLE 54.        Brazil Human microbiome market Revenue And Forecasts to 2025, By Disease (US$ Mn)

TABLE 55.        Brazil Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 56.        Recent Product Launches & Approvals in the Human Microbiome Market

TABLE 57.        Recent EXPANSIONS in the Human Microbiome Market

TABLE 58.        Patent and License Organic Growth Strategies in the Human Microbiome Market

TABLE 59.        Recent Acquisitions in the Human Microbiome market

TABLE 60.        Recent Partnerships & Collaborations in the Human Microbiome market

TABLE 61.        Joint Ventures inOrganic Growth Strategies in the Human Microbiome Market

TABLE 62.        Glossary of Terms, Human microbiome market

 

 

LIST OF FIGURES

FIGURE 1.        Asia Pacific Human microbiome market, Revenue (US$ Mn), By Geography 2018 & 2025

FIGURE 2.        Global human microbiome Market By product, Market Share (%), 2017

FIGURE 3.        Global Human microbiome Market By disease, Market Share (%), 2017

FIGURE 4.        Global Human microbiome Market By application, Market Share (%), 2017

FIGURE 5.        Human microbiome market Segmentation

FIGURE 6.        Human microbiome Segmentation, by region

FIGURE 7.        North America PEST Analysis

FIGURE 8.        Europe PEST Analysis

FIGURE 9.        Asia pacific PEST Analysis

FIGURE 10.     Middle east and africa PEST Analysis

FIGURE 11.     South and central america PEST Analysis

FIGURE 12.     human microbiome market impact analysis of drivers & Restraints

FIGURE 13.     global Human microbiome market – Revenue Forecasts and Analysis – 2017- 2025

FIGURE 14.     global Human microbiome market – by geography Forecasts and Analysis – 2017- 2025

FIGURE 15.     Global Human microbiome market, By Product, 2017 & 2025 (%)

FIGURE 16.     Global foods Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 17.     Global Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 18.     Global Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 19.     Global Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 20.     Global drugs Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 21.     Global DIAGNOSTIC DEVICES Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 22.     Global SUPPLEMENTS Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 23.     Global Human microbiome market By disease, 2017 & 2025 (%)

FIGURE 24.     Global Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 25.     Global Cancer Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 26.     Global Autoimmune Diseases Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 27.     Global Obesity Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 28.     Global MENTAL DISORDERS Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 29.     Global Others Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 30.     Global Human microbiome market By application, 2017 & 2025 (%)

FIGURE 31.     Global diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 32.     Global Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 33.     North America human microbiome market REVENUE overview, by Country, 2017 (US$ MN)

FIGURE 34.     North America human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 35.     North America Human microbiome market Revenue And Forecasts to 2025, By Country (%)

FIGURE 36.     US Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 37.     Canada Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 38.     Mexico Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 39.     Europe Human microbiome market REVENUE overview, by Country, 2017 (US$ MN)

FIGURE 40.     Europe Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 41.     Europe Human microbiome market Revenue And Forecasts to 2025, By Country (%)

FIGURE 42.     UK Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 43.     Germany Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 44.     France Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 45.     Asia Pacific human microbiome Market REVENUE, by Country, 2017 (US$ MN)

FIGURE 46.     asia pacific Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 47.     Asia Pacific Human microbiome Market Revenue And Forecasts to 2025, By Country (%)

FIGURE 48.     China Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 49.     Japan Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 50.     India Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 51.     Middle East and Africa Human microbiome Market REVENUE, by Country, 2017 (US$ MN)

FIGURE 52.     Middle East and Africa Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 53.     UAE Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 54.     Saudi Arabia Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 55.     South Africa Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 56.     South and Central America Human microbiome Market REVENUE, by Country, 2017 (US$ MN)

FIGURE 57.     South and Central America Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 58.     South and Central America Human microbiome Market Revenue And Forecasts to 2025,  By Country (%)

FIGURE 59.     Brazil Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 60.     Impact of COVID-19 Pandemic In North American Country Markets

FIGURE 61.     Impact of COVID-19 Pandemic In European Country Markets

FIGURE 62.     Impact of COVID-19 Pandemic In Asia Pacific Country Markets

FIGURE 63.     Impact Of COVID-19 Pandemic In Rest of the World Market

FIGURE 64.     Growth Strategies in the Human Microbiome Market, 2015-2020

FIGURE 65.     Organic Growth Strategies in the Human Microbiome Market, 2015-2020

FIGURE 66.     Inorganic Growth Strategies in the Endoscopy Device Market, 2015-2018

 

The List of Companies - Human Microbiome Market

  1. Enterome
  2. REBIOTIX INC
  3. YAKULT HONSHA CO., LTD
  4. OSEL INC
  5. VEDANTA BIOSCIENCES, INC
  6. SYNTHETIC BIOLOGICS, INC
  7. DUPONT
  8. BIOMX
  9. MaaT Pharma
  10. Eligo Bioscience
  11. Merck & Co., Inc
  12. AOBiome LLC
  13. Kaleido
  14. Seres Therapeutics
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPBT00002233
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut, the human microbiome consists of the genes these cells harbor. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.

The growth of the market is attributed to the increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing are expected to fuel the market growth. In addition, the human microbiome - a new frontier in drug discovery is likely to have a positive impact on the growth of the market in the coming years

Probiotics are living microorganisms intended to boost the numbers of intestinal bacteria, whereas, prebiotics are types of food that nurture and feeds the human microbiome (or enhance the potential of the bacteria in probiotics). These fiber-full foods provide a balanced diet for the gut bacteria.

Pricing